Searching for synergies: matrix algebraic approaches for efficient pair screening

PLoS One. 2013 Jul 25;8(7):e68598. doi: 10.1371/journal.pone.0068598. Print 2013.

Abstract

Functionally interacting perturbations, such as synergistic drugs pairs or synthetic lethal gene pairs, are of key interest in both pharmacology and functional genomics. However, to find such pairs by traditional screening methods is both time consuming and costly. We present a novel computational-experimental framework for efficient identification of synergistic target pairs, applicable for screening of systems with sizes on the order of current drug, small RNA or SGA (Synthetic Genetic Array) libraries (>1000 targets). This framework exploits the fact that the response of a drug pair in a given system, or a pair of genes' propensity to interact functionally, can be partly predicted by computational means from (i) a small set of experimentally determined target pairs, and (ii) pre-existing data (e.g. gene ontology, PPI) on the similarities between targets. Predictions are obtained by a novel matrix algebraic technique, based on cyclical projections onto convex sets. We demonstrate the efficiency of the proposed method using drug-drug interaction data from seven cancer cell lines and gene-gene interaction data from yeast SGA screens. Our protocol increases the rate of synergism discovery significantly over traditional screening, by up to 7-fold. Our method is easy to implement and could be applied to accelerate pair screening for both animal and microbial systems.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms*
  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Drug Interactions
  • Epistasis, Genetic*
  • Genes, Lethal
  • Genes, Synthetic
  • High-Throughput Screening Assays*
  • Humans
  • Saccharomyces cerevisiae / genetics*

Substances

  • Antineoplastic Agents

Grants and funding

The research received support from the Swedish Research Council (vr.se), the Swedish Cancer Society (cancerfonden.se), and Science for Life Laboratory (scilifelab.uu.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.